A new, staged procedure for univentricular repair of "high risk" patients using a combined surgical transcatheter technique is reported. As first step a surgical hemifontan procedure was performed and a multifenestrated patch inserted into the right atrium. For later transcatheter completion of univentricular repair, a subtotal banding just above the cavoatrial junction was performed. Two months later transcatheter completion was performed by balloon dilatation of the banded cavo-atrial junction and additionally either by inserting a covered stent as intracardiac conduit between the superior and inferior vena cava or by inserting a (non-covered) stent into the cavo-atrial junction and occluding the fenestrations in the right atrial patch using Univentricular repair (Fontan procedure, total cavopulmonary connection) is an established treatment for patients with only one functioning ventricle. However, the hazard of this procedure is still high, depending on ventricular function, the size of the pulmonary arteries, and pulmonary resistance.' 2 The risk of postsurgical death and morbidity has been reduced by fenestrating the baffle between the systemic and pulmonary venous atria, resulting in lower pressures in the superior and inferior vena cava as well as in the right atrium.3-5 For "high-risk" patients, a staged univentricular repair has been proposed,6-8 which consists of a hemifontan procedure as the first stage, during which a surgical anastomosis between the superior vena cava and the (right) pulmonary artery is created. As the second stage, total cavopulmonary connection and thereby completion of univentricular repair is achieved by use of an intracardiac or extracardiac conduit between the inferior vena cava and the pulmonary artery. To reduce the number of operations required to achieve staged univentricular repair and to broaden this therapeutic approach, we combined surgical with interventional techniques to perform staged, total cavopulmonary connection. As the first stage, a modified surgical hemifontan procedure is performed, which prepares the patient for subsequent transcatheter completion of univentricular repair. Completion of total cavopulmonary connection is achieved by transcatheter techniques, eliminating the need for repeated cardiac surgery.
Univentricular repair (Fontan procedure, total cavopulmonary connection) is an established treatment for patients with only one functioning ventricle. However, the hazard of this procedure is still high, depending on ventricular function, the size of the pulmonary arteries, and pulmonary resistance.' 2 The risk of postsurgical death and morbidity has been reduced by fenestrating the baffle between the systemic and pulmonary venous atria, resulting in lower pressures in the superior and inferior vena cava as well as in the right atrium.3-5 For "high-risk" patients, a staged univentricular repair has been proposed,6-8 which consists of a hemifontan procedure as the first stage, during which a surgical anastomosis between the superior vena cava and the (right) pulmonary artery is created. As the second stage, total cavopulmonary connection and thereby completion of univentricular repair is achieved by use of an intracardiac or extracardiac conduit between the inferior vena cava and the pulmonary artery. To reduce the number of operations required to achieve staged univentricular repair and to broaden this therapeutic approach, we combined surgical with interventional techniques to perform staged, total cavopulmonary connection. As the first stage, a modified surgical hemifontan procedure is performed, which prepares the patient for subsequent transcatheter completion of univentricular repair. Completion of total cavopulmonary connection is achieved by transcatheter techniques, eliminating the need for repeated cardiac surgery.
Methods

PATIENTS
In eight patients (age 2-13 years) with increased risk for univentricular repair (mean pulmonary pressure 18 mm Hg or higher, distortion or stenosis of the pulmonary arteries) a two stage univentricular repair combining surgical preconditioning and interventional completion was attempted.' 2 The individual patient data are summarised in table 1.
PROCEDURE
First stage
As the first stage a modified hemifontan operation was performed. The superior vena cava was surgically anastomosed with the right pulmonary artery, while the main pulmonary artery-and when required an aortopulmonary shunt-were ligated. A subtotal banding of the communication between the superior vena cava and the right atrium was performed over a 16 gauge catheter using prolene, so that a minimal communication between the right atrium and the pulmonary artery was maintained for later transcatheter completion. 6-0 Prolene was chosen to perform the banding, as this is easily ruptured during balloon dilatation. Additionally a multiperforated Gore-tex baffle with three to seven perforations 5 mm in diameter was inserted laterally into the right atrium.
Second stage
Two months later the second stage or "trans- d-transposition, 18 MAPCAs swiss cheese VSD valvar and subvalvar PS Age, age at surgical preconditioning; pPA, mean pulmonary pressure; pulmonary vessels, state of the pulmonary vessels; MGA, malposition of the great arteries; DILV, double inlet left ventricle; criss cross, criss cross heart; PS, pulmonary stenosis; RPA, right pulmonary artery; PA banding, banding of the main pulmonary artery; hypoplastic TV, hypoplastic and stenotic tricuspid valve; RV, right ventricle; BT shunt, Blalock-Taussig shunt; MAPCA, major aorto-pulmonary collateral arteries.
catheter completion" of univentricular repair was attempted. Diagnostic cardiac catheterisation was performed from the femoral vein. The pressures in the right atrium and in the superior vena cava were measured. In the first two patients only, general anaesthesia was performed and in addition to the access from the femoral vein a 5F sheath was inserted into the right jugular vein. A guidewire railway (0 035 in, TSF guidewire, 260 cm, Cook) was established from the femoral vein to the jugular vein in these patients, to allow occlusion of the superior vena cava-right atrial junction with a balloon catheter in case of acute cyanosis during the procedure due to preferential flow from the superior vena cava to the right atrium. This was not done in the subsequent patients, in whom sedatation was achieved using diazepam and ketamine.
A right atrial angiogram was performed to delineate the perforations within the right atrial baffle using a 5F pigtail catheter (Cordis). The Technique I-As initial step dilation of the banding site was performed, using a balloon catheter (Opta, Cordis) with a nominal balloon diameter of 6 mm. The balloon catheter was introduced over a 0 035 in guidewire (THSF, 260 cm, Cook) and inflated to an inflation pressure of 2 to 4 atm. The balloon catheter was exchanged for an 8F long sheath (Bard), which had been individually preshaped over hot vapour and was advanced over the 0 035 in guidewire through the banding site. A Palmaz iliac stent (12 mm long, Johnson and Johnson Interventional Systems) was manually mounted on a balloon catheter (Opta, balloon length 2 cm, balloon diameter at nominal pressure 8 mm, Cordis) and advanced over the 0-035 in guidewire through the 8F long sheath until the stent was positioned within the banding site. The long sheath was retrieved and the adequate position of the stent controlled by an angiogram from a venous line in the right cubital vein. Implantation of the stent was performed by inflating the balloon to a pressure of 6 atm. Further expansion of the stent was achieved by inflating the balloon to an inflation pressure of up to 12 atm (diameter 9-2 mm) and then by use of a 10 mm balloon (Opta, 6 atm inflation pressure, Cordis). During this procedure continuous monitoring of the transcutaneous oxygen saturation was performed, to be aware of a significant fall of the arterial oxygen saturation due to an increased blood flow from the superior vena cava to the systemic circulation.
Following balloon dilatation of the superior vena cava-right atrial junction, transcatheter occlusion of the perforations in the baffle was performed. For this purpose the preshaped 8F long sheath was positioned with its tip in the distal inferior vena cava and the perforations within the baffle were crossed with a 5F right Judgkins catheter or Cobra catheter (Cordis). After crossing the baffle a 0 035 in guidewire (260 cm, THSF, Cook) was advanced into a pulmonary vein, the 5F catheter exchanged against the 8F dilator and the 8F long sheath advanced into the left atrium. Using the "front loading technique"9 a 17 mm Rashkind-PDA occluder (Bard) was advanced through this 8F long sheath. When the distal legs of the occluder opened within the left atrium the long sheath was retracted, so that the proximal umbrella could open on the right side of the baffle. After occlusion of the perforations in the baffle, further balloon dilatation of the Palmaz stent was performed to a diameter of 14 to 16 mm.
Technique 2-When the perforations within the baffle were unsuitable for occlusion using Rashkind-PDA occluders because they were located close to the atrial wall or because additional leaks at the suture line of the intracardiac baffle were apparent, a covered wallstent was implanted as an intracardiac conduit. To determine the required length and diameter of the covered wallstent, as well as the length of the covered and uncovered part of the stent, angiograms of the superior vena cava, the right atrium, the inferior vena cava, and the hepatic veins were performed as described above. According to these measurements, a covered wallstent was individually manufactured by Medinvent (Schneider, Switzerland) as "intracardiac conduit" between the superior and inferior vena cava. Implantation of the covered wallstents was performed after informed consent and approval by the local ethics committee had been obtained. The banding site was predilated to a diameter of 16 mm as described above. The covered wallstent was then inserted from the femoral vein over a 0-035 in guidewire transcutaneously. Predilatation of the femoral vein was performed to insert the 18F delivery instrument for the covered wallstent. Anticoagulation During the procedure 100 U/kg heparin were given intravenously, and the antithrombin III blood level was kept above 90%. After the procedure heparin was continued and dicoumarol was started. The latter was given for four months. Heparin was given as a continuous infusion. During the first 24 hours 600 IU/kg were given, followed by 400 IU/kg/d until the international normalised ratio (INR) was Only the first two procedures were performed during general anaesthesia. In these two patients both the right femoral vein and the right jugular vein were punctured, and a guidewire railway from the femoral vein and to the jugular vein was established. Because the interventional completion turned out to be rather uncomplicated, without deleterious decrease in the arterial oxygen saturation, general anaesthesia and puncture of the right jugular vein were abandoned in the subsequent patients. The communication between the superior vena cava and the right atrium had a minimum diameter of 0 2 to 0 5 mm. In two patients predilatation using a PTCA catheter (Olimpix, balloon length 2 cm, inflated balloon diameter at nominal pressure 3 mm; Cordis) which was inflated to a pressure of 6 atm was necessary to be able to cross the banding site with a diagnostic catheter. After diagnostic catheterisation, incremental balloon dilatation of the cavo-atrial junction was performed to a diameter of 10 mm. The waist in the balloon disappeared at an inflation 1  23  6  88  8  9  78  9  9  71  8  10  96  2  20  9  86  9  6  79  7  7  73  8  8  91  3  19  9  88  8  7  75  7  6  72  7  7  97  4  18  12  80  9  9  76  8  7  73  7  9  94  5  22  12  80  7  7  79  6  7  74  7  8  96  6  20  9  83  8  9  79  7  8  76  6  8  88  7  18  9  79  10  10  87  7  7  81  6  7  92  8  18  9  71  8  8  83  7  7  79  7  7  94 pPA, mean pulmonary arterial pressure (mm Hg); pRA, mean right atrial pressure (mm Hg); Sat, arterial oxygen saturation (%). pressure of 3 to 4 atm during angioplasty of the iatrogenic stricture of the cavo-atrial junction. Surprisingly, the arterial oxygen saturation did not decrease significantly during this part of the procedure, although the fenestrations within the baffle were still patent. In six patients a Palmaz stent (12 mm iliac stent, Johnson and Johnson interventional) was implanted into the cavo-atrial junction and dilated up to a diameter of 13-16 mm. The Palmaz stents shortened from a length of 12 mm to 10-6 mm when expanded to a diameter of 10 mm, to a length of 9-8 mm when expanded to a diameter of 12 mm, to a length of 8-4 mm when expanded to a diameter of 14 mm, and to a length of 7-4 mm when expanded to a diameter of 16 mm. Thereafter the multiperforated patch was occluded using two to five "large" (17 mm diameter) Rashkind-PDA occluders (Bard) through the 8F long sheath, which had been inserted for stent implantation (fig 1) .
In two patients, leaks at the suture line of the intracardiac baffle were apparent in addition to the fenestrations within the baffle. Balloon sizing of these defects (6F Berman end open catheter with a 16 mm latex balloon, special request, Arrows) revealed a defect diameter of 10 mm and 12 mm, so that these leaks were not suitable for closure using Rashkind-PDA occluders. In these two patients a covered wallstent (Medinvent, Switzerland) was implanted after predilating the communication between superior vena cava and right atrium sequentially to a diameter of 14 mm and 16 mm. The covered wallstents had an expanded diameter of 20 mm and length of 65 mm. Both ends of these covered wallstents were left uncovered, distally 1 cm, proximally 1-5 cm. Implantation was performed transcutaneously, from the femoral vein using an 18F delivery system. The length of the stent in the delivery system (before expansion) was 10 cm. The covered wallstents were implanted between the superior vena As the first step in this new concept, a hemifontan-type circulation is established surgically, concomitantly preconditioning the patient for later transcatheter Fontan completion. This is achieved by maintaining a minimal communication between the superior vena cava and the right atrium and by inserting a multiperforated baffle laterally into the right sided atrium. The main goal of unloading the systemic ventricle is achieved by this first (surgical) stage, the systemic ventricle being allowed to remodel before transcatheter completion of the univentricular repair is performed. In our experience the postsurgical course after the first (surgical) stage was as smooth as after bidirectional Glenn operation, with none of the complications that are typical of Fontan-like procedures.
The major advantage of this new concept is that repeated surgery can be reduced; additionally myocardial ischaemia does not occur during completion of univentricular repair. Although increased cyanosis during the interventional procedure was a matter of concern, no increase in right to left shunting occurred after balloon dilatation of the cavo-atrial junction when the fenestrations in the baffle were still patent. As the conversion from a hemiFontan to a Fontan-type circulation proved to be smooth, only the first two procedures were performed under general anaesthesia, while the subsequent procedures were performed under sedation. Complications typical for Fontan-type corrections were not observed in any of our patients after surgical preconditioning or after transcatheter completion. The mean right atrial pressure increased from 7-4 mm Hg to 7-6 mm Hg during transcatheter completion. The smooth and uneventful clinical course during and after both stages suggests that the risks inherent to the surgical establishment of a Fontan-type circulation can be further reduced by this approach.
Despite these promising experiences, some potential disadvantages should be mentioned. For the surgical preconditioning, extracorporeal circulation is necessary to insert the multiperforated baffle. However, the cross clamp time was reduced continuously from 79 minutes in the first patient to 19 minutes in the last patient. Additionally, stent implantation into the cavo-atrial junction could be a matter of concern because of alteration of the sinus node. Therefore the banding was performed as near as possible to the cavopulmonary anastomoses, and the stents were placed as high as possible in the superior vena cava to prevent mechanical interference with the sinus node. Sinus node dysfunction was not observed in any of our patients during the follow up period of four to 14 months. Another matter of concern could be that an implanted endovascular stent does not allow growth of the cavo-atrial junction, in contrast to surgical techniques. However, the Palmaz stents used can be redilated to a diameter of 20 mm. Although dilatation of these stents is recommended to a diameter of 16 mm, expansion up to 20 mm is possible in our experience. We believe a cavopulmonary junction with a diameter of 20 mm should give adequate communication. We would not perform angioplasty or recommend surgery on a cavo-pulmonary junction with a diameter of 18 to 20 mm after total cavopulmonary connection or another Fontan-type procedure. Such a diameter is equal to that of an extracardiac conduit which is implanted surgically.'8 Finally, tissue growth or thrombotic deposits within the covered wallstent observed in one patient could be a matter of concern ( fig 2B) ; however, no pressure gradient within the stent was observed, and this tissue had regressed 12 months after the implantation ( fig 2C) . Despite this, we suggest that anticoagulation with dicoumarol is necessary after implantation of a covered wallstent to prevent thrombotic deposits within the covered wallstents.
Until more experience with this new approach is gained, and long term follow up data acquired, it cannot be decided which of the two techniques used for transcatheter Fontan completion is to be preferred: implanting a covered wallstent as an "intracardiac conduit" or restricting stent implantation to the cavo-atrial junction with subsequent occlusion of the multiperforated baffle with umbrellas. The use of a covered wallstent as intracardiac conduit offers the advantage of excluding the right atrium from the circulation, thereby protecting it from distension by an increased venous pressure, and hence reducing the incidence of late dysrhythmias. However, restricting stent implantation to the cavo-atrial junction with subsequent umbrella closure of the multiperforated baffle offers the advantage of leaving a residual leak in the baffle, converting the hemifontan circulation to a "fenestrated" Fontan circulation, with the option of occluding this residual fenestration later. Using this approach the interventional Fontan completion can be staged, allowing a smooth conversion to a univentricular repair according to the Fontan principle, potentially reducing morbidity and improving quality of life.
